Tay-Sachs disease is a lysosomal storage disorder that is caused by a mutation in the HexA gene coding for the alpha subunit of lysosomal B-hexosaminidase A. HexA is responsible for the removal of N-acetylglucosamine residue form GM2 ganglioside to convert it into GM3 in the ganglioside degradation pathway. Deficiency of HexA causes neuronal death with progressive neurological degeneration. Neu4 is a sialidese and found in lysosomes. Knock-out mice model of Neu4-/- show different ganglioside pattern than wild type mice and there is increased GD1a and decreased GM1 in brains of mice (Seyrantepe et al. 2008). As previously shown, Neu4 is a modifier gene of HexA. On a previous work (Seyrantepe et al. 2010) Neu4-/-HexA-/- double deficient mouse showed more severe phenotype than HexA-/- deficiency alone. 1,4-N-acetylgalactosaminyltransferase; (Galgt1) is one of the key enzymes in the synthesis of complex gangliosides and it work in reverse direction of HexA. In the deficiency of Galgt1, there is only production of simple gangliosides occurs. Absence of complex gangliosides causes neurological degeneration. Mouse model of Neu4-/-HexA-/-Galgt1-/- was generated as a model of substrate deprivation therapy. That mouse has defects in both ganglioside synthesis and degradation mechanisms, so neither synthesis nor degradation of complex gangliosides will occur. By this mean, effects of Tay-Sachs disease were decreased. On previously shown Neu4 has role in the metabolism of GD1a into GM1. With this study, it was speculated that sialidase Neu4 may play a role in the metabolism of simple gangliosides. Key Words: Lysosome, Sialidase, Mouse, Tay-Sachs